Literature DB >> 15100115

Blood pool MR angiography of aortic stent-graft endoleak.

Hale Ersoy1, Paula Jacobs, Craig K Kent, Martin R Prince.   

Abstract

OBJECTIVE: The purpose of our research was to investigate the value of a blood pool contrast agent in detecting endoleaks on MR angiography after endoluminal stent-graft repair of infrarenal aortic aneurysms.
CONCLUSION: Blood pool MR angiography using Ferumoxytol reveals more aortic stent-graft endoleaks than does CT angiography and depicts more endoleaks 24 hr after administration than during the immediate arterial phase because of a 50-fold increase in the volume of enhancement in the aneurysmal sac outside the stent-graft.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100115     DOI: 10.2214/ajr.182.5.1821181

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

1.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.

Authors:  Ali C M Johnson; Kirsten Becker; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

Review 2.  Endoleakage after endovascular treatment of abdominal aortic aneurysms: Diagnosis, significance and treatment.

Authors:  Jafar Golzarian; David Valenti
Journal:  Eur Radiol       Date:  2006-04-11       Impact factor: 5.315

3.  Comparative analysis of fluorescent angiography, computed tomographic angiography and magnetic resonance angiography for planning autologous breast reconstruction.

Authors:  Michael P Chae; David J Hunter-Smith; Warren Matthew Rozen
Journal:  Gland Surg       Date:  2015-04

Review 4.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 5.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

6.  Planning deep inferior epigastric perforator flaps for breast reconstruction: a comparison between multidetector computed tomography and magnetic resonance angiography.

Authors:  A Cina; L Barone-Adesi; P Rinaldi; A Cipriani; M Salgarello; R Masetti; L Bonomo
Journal:  Eur Radiol       Date:  2013-04-10       Impact factor: 5.315

Review 7.  A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Jean-Marc Idée
Journal:  Quant Imaging Med Surg       Date:  2017-02

Review 8.  Molecular imaging of cerebrovascular lesions.

Authors:  Nohra Chalouhi; Pascal Jabbour; Vincent Magnotta; David Hasan
Journal:  Transl Stroke Res       Date:  2013-10-23       Impact factor: 6.829

Review 9.  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Authors:  Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt
Journal:  Kidney Int       Date:  2017-04-20       Impact factor: 10.612

10.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.